Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

CNS-border associated macrophages respond to acute ischemic stroke attracting granulocytes and promoting vascular leakage

  • Pedragosa, Jordi
  • Salas-Perdomo, Angélica
  • Gallizioli, Mattia
  • Cugota, Roger
  • Miró-Mur, Francesc
  • Briansó, Ferran
  • Justicia, Carles
  • Pérez-Asensio, Fernando J.
  • Márquez-Kisinousky, Leonardo
  • Urra, Xabier
  • Gieryng, Anna
  • Kaminska, Bozena
  • Chamorro, Ángel
  • Planas, Anna M.
The central nervous system (CNS) contains several types of immune cells located in specific anatomic compartments. Macrophages reside at the CNS borders surrounding the brain vessels, in leptomeningeal spaces and the choroid plexus, where they interact with the vasculature and play immunological surveillance and scavenging functions. We investigated the phenotypic changes and role of these macrophages in response to acute ischemic stroke. Given that CD163 expression is a hallmark of perivascular and meningeal macrophages in the rat and human brain, we isolated CD163+ brain macrophages by fluorescence activated cell sorting. We obtained CD163+ cells from control rats and 16 h following transient middle cerebral artery occlusion, after verifying that infiltration of CD163+ peripheral myeloid cells is negligible at this acute time point. Transcriptome analysis of the sorted CD163+ cells identified ischemia-induced upregulation of the hypoxia inducible factor-1 pathway and induction of genes encoding for extracellular matrix components and leukocyte chemoattractants, amongst others. Using a cell depletion strategy, we found that CNS border-associated macrophages participate in granulocyte recruitment, promote the expression of vascular endothelial growth factor (VEGF), increase the permeability of pial and cortical blood vessels, and contribute to neurological dysfunction in the acute phase of ischemia/reperfusion. We detected VEGF expression surrounding blood vessels and in some CD163+ perivascular macrophages in the brain tissue of ischemic stroke patients deceased one day after stroke onset. These findings show ischemia-induced reprogramming of the gene expression profile of CD163+ macrophages that has a rapid impact on leukocyte chemotaxis and blood-brain barrier integrity, and promotes neurological impairment in the acute phase of stroke., Supported by the Spanish Ministerio de Economia y Competitividad (SAF2014–56279-R and SAF2017–87459-R). JP and MG were supported by a PhD fellowship from the Catalan Research Agency (AGAUR) and the ITN program of the European Community (NeuroInflammation, FP7-PEOPLE-2013-ITN-n°607962), respectively. FMM is recipient of an ICT award by the Pla estratègic de recerca i innovació en salut (PERIS) of the Departament de Salut, Generalitat de Catalunya.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

CD69 Plays a Beneficial Role in Ischemic Stroke by Dampening Endothelial Activation

  • Brait, Vanessa
  • Miró-Mur, Francesc
  • Pérez-de-Puig, Isabel
  • Notario, Laura
  • Hurtado Villarejo, Begoña
  • Pedragosa, Jordi
  • Gallizioli, Mattia
  • Jiménez-Altayó, Francesc
  • Arbaizar-Rovirosa, María
  • Otxoa de Amezaga, Amaia
  • Monteagudo, Juan
  • Ferrer-Ferrer, Maura
  • Rosa, Xavier de la
  • Bonfill-Teixidor, Ester
  • Salas-Perdomo, Angélica
  • Hernández-Vidal, Alba
  • García de Frutos, Pablo
  • Lauzurica, Pilar
  • Planas, Anna M.
RATIONALE: CD69 is an immunomodulatory molecule induced during lymphocyte activation. Following stroke, T-lymphocytes upregulate CD69 but its function is unknown. OBJECTIVE: We investigated whether CD69 was involved in brain damage following an ischemic stroke. METHODS AND RESULTS: We used adult male mice on the C57BL/6 or BALB/c backgrounds, including wild-type mice and CD69-/- mice, and CD69+/+ and CD69-/- lymphocyte-deficient Rag2-/- mice, and generated chimeric mice. We induced ischemia by transient or permanent middle cerebral artery occlusion. We measured infarct volume, assessed neurological function, and studied CD69 expression, as well as platelet function, fibrin(ogen) deposition, and VWF (von Willebrand factor) expression in brain vessels and VWF content and activity in plasma, and performed the tail-vein bleeding test and the carotid artery ferric chloride-induced thrombosis model. We also performed primary glial cell cultures and sorted brain CD45-CD11b-CD31+ endothelial cells for mRNA expression studies. We blocked VWF by intravenous administration of anti-VWF antibodies. CD69-/- mice showed larger infarct volumes and worse neurological deficits than the wild-type mice after ischemia. This worsening effect was not attributable to lymphocytes or other hematopoietic cells. CD69 deficiency lowered the time to thrombosis in the carotid artery despite platelet function not being affected. Ischemia upregulated Cd69 mRNA expression in brain endothelial cells. CD69-deficiency increased fibrin(ogen) accumulation in the ischemic tissue, and plasma VWF content and activity, and VWF expression in brain vessels. Blocking VWF reduced infarct volume and reverted the detrimental effect of CD69-/- deficiency. CONCLUSIONS: CD69 deficiency promotes a prothrombotic phenotype characterized by increased VWF and worse brain damage after ischemic stroke. The results suggest that CD69 acts as a downregulator of endothelial activation., The study was funded by the Spanish Ministerio de Economía y Competitividad (MINECO; grant SAF2014-56279-R and SAF2017-87459-R to A.M. Planas), Acción Estratégica de Salud (grants AES 1366/13 and AESI 1346/16 to P. Lauzurica), and Fundació la Marató de TV3 (grants 474-082230 and 20153031 to P. Garcia-de-Frutos). F. Miró-Mur had a PERIS award by the Health Department of the Generalitat de Catalunya. A. Otxoa-de-Amezaga has an FPI fellowship (MINECO).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Microglial cell loss after ischemic stroke favors brain neutrophil accumulation

  • Otxoa de Amezaga, Amaia
  • Miró-Mur, Francesc
  • Pedragosa, Jordi
  • Gallizioli, Mattia
  • Justicia, Carles
  • Gaja-Capdevila, Núria
  • Ruíz-Jaén, Francisca
  • Salas-Perdomo, Angélica
  • Bosch, Anna
  • Calvo, María
  • Márquez-Kisinousky, Leonardo
  • Denes, Adam
  • Gunzer, Matthias
  • Planas, Anna M.
Stroke attracts neutrophils to the injured brain tissue where they can damage the integrity of the blood–brain barrier and exacerbate the lesion. However, the mechanisms involved in neutrophil transmigration, location and accumulation in the ischemic brain are not fully elucidated. Neutrophils can reach the perivascular spaces of brain vessels after crossing the endothelial cell layer and endothelial basal lamina of post-capillary venules, or migrating from the leptomeninges following pial vessel extravasation and/or a suggested translocation from the skull bone marrow. Based on previous observations of microglia phagocytosing neutrophils recruited to the ischemic brain lesion, we hypothesized that microglial cells might control neutrophil accumulation in the injured brain. We studied a model of permanent occlusion of the middle cerebral artery in mice, including microglia- and neutrophil-reporter mice. Using various in vitro and in vivo strategies to impair microglial function or to eliminate microglia by targeting colony stimulating factor 1 receptor (CSF1R), this study demonstrates that microglial phagocytosis of neutrophils has fundamental consequences for the ischemic tissue. We found that reactive microglia engulf neutrophils at the periphery of the ischemic lesion, whereas local microglial cell loss and dystrophy occurring in the ischemic core are associated with the accumulation of neutrophils first in perivascular spaces and later in the parenchyma. Accordingly, microglia depletion by long-term treatment with a CSF1R inhibitor increased the numbers of neutrophils and enlarged the ischemic lesion. Hence, microglial phagocytic function sets a critical line of defense against the vascular and tissue damaging capacity of neutrophils in brain ischemia., Supported by grants of the Ministerio de Economía y Competitividad (MINECO) (SAF2014-56279-R and SAF2017-87459-R).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Role of the S1P pathway and inhibition by fingolimod in preventing hemorrhagic transformation after stroke

  • Salas-Perdomo, Angélica
  • Miró-Mur, Francesc
  • Gallizioli, Mattia
  • Brait, Vanessa
  • Justicia, Carles
  • Meissner, Anja
  • Urra, Xabier
  • Chamorro, Ángel
  • Planas, Anna M.
Hemorrhagic transformation (HT) is a complication of severe ischemic stroke after revascularization. Patients with low platelet counts do not receive reperfusion therapies due to high risk of HT. The immunomodulatory drug fingolimod attenuated HT after tissue plasminogen activator in a thromboembolic stroke model, but the underlying mechanism is unknown. Fingolimod acts on several sphingosine-1-phosphate (S1P) receptors, prevents lymphocyte trafficking to inflamed tissues, and affects brain and vascular cells. This study aimed to investigate changes in S1P-signaling in response to brain ischemia/reperfusion and the effects of the S1P receptor modulator fingolimod on HT. We studied brain expression of S1P signaling components, S1P concentration, and immune cell infiltration after ischemia/reperfusion in mice. We administered fingolimod after ischemia to wild-type mice, lymphocyte-deficient Rag2 mice, and mice with low platelet counts. Ischemia increased S1P-generating enzyme SphK1 mRNA, S1P concentration, and S1P receptor-1 (S1P1) T-cells in the brain. Fingolimod prevented lymphocyte infiltration, and attenuated the severity of HT in Rag2 mice but it was ineffective under thrombocytopenia. Fingolimod prevented β-catenin degradation but not Evans blue extravasation. Ischemia/reperfusion upregulates brain S1P signaling pathway, and fingolimod exerts local effects that attenuate HT. Although fingolimod seems to act on the brain tissue, it did not prevent blood-brain barrier leakage., Supported by a grant from the Spanish Ministerio de Economía y Competitividad (SAF2017-87459-R to AMP), and a grant FIS (PI15/00430 to AC) co-financed by the Instituto de Salud Carlos III (ISCIII)-Subdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER).We are grateful to David Bellido from the Centres Científics i Tecnològics of the University of Barcelona for the mass spectrometry analyses. We thank the Pla Estratègic de Recerca i Innovació en Salut (PERIS) program of the Health Department of the Generalitat de Catalunya for supporting FMM, the Centre de Recerca Biomèdica Cellex, Barcelona, where part of this work was performed, and the Centres de Recerca de Catalunya (CERCA) Programme of the Generalitat de Catalunya for supporting the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Location of Neutrophils in Different Compartments of the Damaged Mouse Brain After Severe Ischemia/Reperfusion

  • Otxoa de Amezaga, Amaia
  • Gallizioli, Mattia
  • Pedragosa, Jordi
  • Justicia, Carles
  • Miró-Mur, Francesc
  • Salas-Perdomo, Angélica
  • Díaz-Marugan, Laura
  • Planas, Anna M.
Background and Purpose- Ischemia attracts neutrophils to the injured brain. However, neutrophil location and access to the damaged brain tissue is not yet entirely understood. We aimed to investigate neutrophil location in a mouse model of cerebral ischemia/reperfusion. Methods- Adult male C57BL/6 mice (n=52) received 45-minute intraluminal middle cerebral artery occlusion followed by 14, 24, 48, or 96 hours of reperfusion. Sham-operated mice (n=9) were subjected to the entire surgical procedure. We used wild-type mice and CatchupIVM mice expressing a red fluorescent protein in neutrophils. In addition, fluorescent neutrophils obtained from reporter DsRed (discosoma red fluorescent protein) mice were transferred intravenously to wild-type mice after ischemia. Mice received transcardial paraformaldehyde perfusion, the brain was cryoprotected, frozen, and cryostat sections were studied by immunofluorescence and confocal microscopy. Results- Ischemia induced a time-dependent increase in brain neutrophil numbers versus sham operation. We detected neutrophils in the leptomeninges, ventricles, capillary lumen, perivascular spaces, and parenchyma within the infarcted core. Most ischemic mice showed neutrophils in the leptomeninges and perivascular spaces, whereas the presence and number of neutrophils in the parenchyma was variable among ischemic mice. During the first 24 hours, only a few mice showed parenchymal neutrophils, but the frequency of mice showing neutrophils in the parenchyma and neutrophil numbers increased at 48 and 96 hours. We also detected signs of basement membrane disruption and hints of occasional neutrophil degranulation and formation of neutrophil extracellular traps. Conclusions- After ischemia/reperfusion, neutrophils accumulate in the leptomeninges and perivascular spaces, and eventually can reach the infarcted brain parenchyma., This work was supported by the Spanish Ministerio de Economía y Competitividad (MINECO; SAF2017-87459-R). The predoctoral programs of MINECO (formación de personal investigador) and Fundació La Caixa (ID 100010434) supported A. Otxoa-de-Amezaga and L. Díaz-Marugan, respectively. The Pla Estratègic de Recerca i Innovació en Salut (PERIS) program of the Health Department of Generalitat de Catalunya supported Dr Miró-Mur.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Defining molecular identity and fates of CNS-border associated macrophages after ischemic stroke in rodents and humans

  • Rajan, Wenson D.
  • Wojtas, Bartosz
  • Gielniewski, Bartlomiej
  • Miró-Mur, Francesc
  • Pedragosa, Jordi
  • Zawadzka, Malgorzata
  • Pilanc, Paulina
  • Planas, Anna M.
  • Kaminska, Bozena
Central nervous system (CNS)-border associated macrophages (BAMs) maintain their steady-state population during adulthood and are not replaced by circulating monocytes under physiological conditions. Their roles in CNS integrity and functions under pathological conditions remain largely unknown. Until recently, BAMs and microglia could not be unequivocally distinguished due to expression of common macrophage markers. We investigated the transcriptional profiles of immunosorted BAMs from rat sham-operated and ischemic brains using RNA sequencing. We found that BAMs express the distinct transcriptional signature than microglia and infiltrating macrophages. The enrichment of functional groups associated with the cell cycle in CD163 cells isolated 3 days after the ischemic injury indicates the proliferative capacity of these cells. The increased number of CD163 cells 3 days post-ischemia was corroborated by flow cytometry and detecting the increased number of CD163 cells positive for a proliferation marker Ki67 at perivascular spaces. CD163 cells in the ischemic brains up-regulated many inflammatory genes and parenchymal CD163+ cells expressed iNOS, which indicates acquisition of a pro-inflammatory phenotype. In mice, BAMs typically express CD206 and we found a subset of these cells expressing CD169. Chimeric mice generated by transplanting bone marrow of donor Cx3cr1CCR2 mice to wild type hosts showed an increased number of CX3CR1CD169 perivascular macrophages 3 days post-ischemia. Furthermore, these cells accumulated in the brain parenchyma and we detected replacement of perivascular macrophages by peripheral monocytic cells in the sub-acute phase of stroke. In line with the animal results, post-mortem brain samples from human ischemic stroke cases showed time-dependent accumulation of CD163 cells in the ischemic parenchyma. Our findings indicate a unique transcriptional signature of BAMs, their local proliferation and migration of inflammatory BAMs to the brain parenchyma after stroke in animal models and humans., Studies were supported by the FP7-PEOPLE-2013-ITN grant n607962 (WDR) and CePT infrastructure fund from the European Union – the European Regional development Fund within the Operational Programme “Innovative Economy” for 2007–2013 and the Spanish Ministerio de Economia y Competitividad (MINECO, SAF2017-87459-R). We thank the Cytometry and Image Platforms of IDIBAPS and the Nencki institute for technical support. We are indebted to the Neurological Tissue Bank of the Biobank-Hospital Clinic-IDIBAPS for sample and data procurement, and to patient's relatives for giving consent to use the brain tissue. The use of CePT infrastructure financed by the European Union - The European Regional Development Fund within the Operational Programme "Innovative economy" for 2007-2013 is highly appreciated.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Dendritic Cells and Microglia Have Non-redundant Functions in the Inflamed Brain with Protective Effects of Type 1 cDCs

  • Gallizioli, Mattia
  • Miró-Mur, Francesc
  • Otxoa de Amezaga, Amaia
  • Cugota, Roger
  • Salas-Perdomo, Angélica
  • Justicia, Carles
  • Brait, Vanessa
  • Ruíz-Jaén, Francisca
  • Arbaizar-Rovirosa, María
  • Pedragosa, Jordi
  • Bonfill-Teixidor, Ester
  • Gelderblom, Mathias
  • Magnus, Tim
  • Cano, Eva
  • Fresno, Carlos del
  • Sancho, David
  • Planas, Anna M.
CD11c dendritic cells infiltrate the brain after ischemic injury and share some features with microglia. Gallizioli et al. show that dendritic cells exhibit a transcriptional profile different from microglia and excel in antigen presentation. Microglia attract different DC subsets via chemokines, especially cDC1 that exert beneficial functions in cerebral ischemia.Brain CD11c cells share features with microglia and dendritic cells (DCs). Sterile inflammation increases brain CD11c cells, but their phenotype, origin, and functions remain largely unknown. We report that, after cerebral ischemia, microglia attract DCs to the inflamed brain, and astroglia produce Flt3 ligand, supporting development and expansion of CD11c cells. CD11c cells in the inflamed brain are a complex population derived from proliferating microglia and infiltrating DCs, including a major subset of OX40L conventional cDC2, and also cDC1, plasmacytoid, and monocyte-derived DCs. Despite sharing certain morphological features and markers, CD11c microglia and DCs display differential expression of pattern recognition receptors and chemokine receptors. DCs excel CD11c and CD11c microglia in the capacity to present antigen through MHCI and MHCII. Of note, cDC1s protect from brain injury after ischemia. We thus reveal aspects of the dynamics and functions of brain DCs in the regulation of inflammation and immunity., This work was funded by Ministerio de Ciencia, Innovación y Universidades (MICINN) co-financed by Fondo Europeo de Desarrollo Regional (FEDER) ( SAF2017-87459-R ), the European Union (EU) ( H2020-ITN-2018-813294-ENTRAIN ), and Fundació Marató TV3 ( 201723 to A.M.P. and D.S.). Work in the D.S. laboratory is funded by Centro Nacional de Investigaciones Cardiovasculares (CNIC), the European Research Council (ERC-2016-Consolidator Grant 725091 ), the EU ( 635122-PROCROP H2020 ), and MICINN-FEDER ( SAF2016-79040-R ). The EU ( FP7-PEOPLE-2013-ITN-n°07962 ) supported M. Gallizioli. The PERIS program of Generalitat de Catalunya supported F.M.-M. A.O.-d.-A. had a fellowship from MICINN-FPI ( BES-2015-074419 ). C.d.F. is supported by the AECC Foundation ( INVES192DELF ). We thank Anaxomics, the genomics and informatics BioCore Units of Centre for Genomic Regulation, the Cytomics and Experimental 7T MRI platforms of IDIBAPS, and the Advanced Optical Microscopy Unit-CCiT of the University of Barcelona for technical support. We thank Dr. U. Perpiñá for microscopy assistance. Plexxikon Inc. provided PLX5622 under a materials transfer agreement. Part of this work was performed at Centre de Recerca Biomèdica Cellex. The Centres de Recerca de Catalunya (CERCA) Program of Generalitat de Catalunya supports IDIBAPS.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Top ten discoveries of the year: Neurovascular disease

  • Planas, Anna M.
The aim of this review is to highlight novel findings in 2019 in the area of neurovascular disease. Experimental studies have provided insight into disease development, molecular determinants of pathology, and putative novel therapeutic targets. Studies in genetic experimental models as well as monogenic forms of human cerebrovascular diseases identified pathogenic molecules that may also be relevant to sporadic cases. There have been advances in understanding the development of cerebral cavernous angiomas and arteriovenous malformations, and putative curative treatments have been suggested from experimental models. Key pathogenic pathways involved in vessel calcification and stiffness have also been identified. At the cellular level, studies showed that proper function of endothelial and mural cells, particularly pericytes, is crucial to ensure full endothelial differentiation and blood-brain barrier integrity. Moreover, recent discoveries support the existence of a homeostatic crosstalk between vascular cells and other neural cells, including neurons. Cerebrovascular diseases are strongly associated with inflammation. Beyond pathogenic roles of specific components of the inflammatory response, new discoveries showed interesting interactions between inflammatory molecules and regulators of vascular function. Clinical investigation on cerebrovascular diseases has progressed by combining advanced imaging and genome-wide association studies. Finally, vascular cognitive impairment and dementia are receiving increasing attention. Recent findings suggest that high-salt intake may cause cerebrovascular dysfunction and cognitive impairment independent of hypoperfusion and hypertension. These and other recent reports will surely inspire further research in the field of cerebrovascular disease that will hopefully contribute to improved prevention and treatment., Supported by the Spanish Ministry of Science, In-novation and Universities (SAF2017-87459-R), Peer reviewed